EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Prolactin's paradox: Friend, foe, or both in immune regulation?

Vânia Borba, Pedro Carrera-Bastos, Gisele Zandman-Goddard, Alejandro Lucia, Yehuda Shoenfeld

Autoimmunity Reviews · 2024-11 · 23 (11) · 103643

DOI: 10.1016/j.autrev.2024.103643 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Autoimmunity Reviews, 2024-11. Verfasst von Vânia Borba und 4 weiteren Autor:innen. Beteiligte Einrichtung: Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel; Internal Medicine, Rehaklinik Dussnang, Thurgau, Switzerland.…. Hauptthemen laut MEDLINE: Prolactin, Autoimmune Diseases. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 111 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Over 100 diseases have been recognized as autoimmune in nature, collectively affecting ∼20 % of the population in industrialized countries. These conditions are more prevalent among women of childbearing age, reflecting the potential association between alterations in the immune-neuroendocrine network, on the one hand, and autoimmune conditions, on the other. Prolactin (PRL), a polypeptide hormone that is primarily (but not only) secreted by the lactotrophic cells of the pituitary gland, is a critical element of the immune-neuroendocrine network. Although this hormone has several nonimmune functions, its role in regulating immune responses and affecting autoimmune inflammation is particularly enigmatic and controversial. Indeed, PRL interacts with various immune cells to bolster the body defenses, but also potentially to exacerbate autoimmune conditions. Understanding how and when PRL acts as a 'friend or foe' is crucial for unraveling its role as a potential therapeutic target in the management of autoimmune diseases (AIDs). This review therefore provides a critical overview of PRL's role in the immune system, and of the influence of this pleiotropic hormone in the development of autoimmunity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProlactinAutoimmune DiseasesHumansAnimalsAutoimmunityImmune SystemImmunomodulation

Stichwörter der Autor:innen

Autoimmune diseasesCytokineHormoneHyperprolactinemiaMacroprolactinProlactin

Substanzen

Prolactin

Autor:innen und Institutionen

  • Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel; Internal Medicine, Rehaklinik Dussnang, Thurgau, Switzerland. Electronic address: vaniavborba@gmail.com.
  • Center for Primary Health Care Research, Department of Clinical Sciences, Malmö, Lund University, Lund, Sweden; Faculty of Biomedical and Health Sciences, Universidad Europea de Madrid, Madrid, Spain.
  • Department of Medicine C, Wolfson Medical Center, Holon, Israel; Department of Rheumatology, Wolfson Medical Center, Holon, Israel; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Faculty of Sport Sciences, Universidad Europea de Madrid, Madrid, Spain; Physical Activity and Health Research Group ('PaHerg'), Research Institute of the Hospital 12 de Octubre ('imas12'), Madrid, Spain.
  • Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel; Reichman University, Herzliya, Israel.

Zitieren

APA

Borba, V., Carrera-Bastos, P., Zandman-Goddard, G., Lucia, A., & Shoenfeld, Y. (2024). Prolactin's paradox: Friend, foe, or both in immune regulation?. Autoimmunity Reviews, 23(11), 103643. https://doi.org/10.1016/j.autrev.2024.103643

Vancouver

Borba V, Carrera-Bastos P, Zandman-Goddard G, Lucia A, Shoenfeld Y. Prolactin's paradox: Friend, foe, or both in immune regulation?. Autoimmunity Reviews. 2024;23(11):103643. doi:10.1016/j.autrev.2024.103643

BibTeX
@article{Borba2024,
  author = {Borba, Vânia and Carrera-Bastos, Pedro and Zandman-Goddard, Gisele and Lucia, Alejandro and Shoenfeld, Yehuda},
  title = {Prolactin's paradox: Friend, foe, or both in immune regulation?},
  journal = {Autoimmunity Reviews},
  year = {2024},
  volume = {23},
  number = {11},
  pages = {103643},
  doi = {10.1016/j.autrev.2024.103643}
}
Kostenlos starten →